'A new study shows that so-called “good” cholesterol, HDL, is increased, and so-called “bad” cholesterol, LDL, is decreased by a new, as yet unreleased drug, evacetrapib. To be published this week in theJournal of the American Medical Association (JAMA), the study demonstrates that HDL can be more than doubled compared with placebo and LDL decreases up to one-third.
That does, of course sound good.
Having higher HDL levels and lower LDL levels are good for us, right?'
Read more...
Related Post:
Widget by [ Iptek-4u ]
